|
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL). |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Inflax; Merck Serono; MSD; Novartis; Pierre Fabre; Roche; Sanofi |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi |
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi |
Other Relationship - Avantis Medical Systems; BMS; InflaRx; Jazz Pharmaceuticals; MSD; Novartis; Pierre Fabre; Sanofi |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Mexico); MSD |
|
|
Travel, Accommodations, Expenses - Abbvie; Novartis |
|
Claudia Luisa Bejar Ardiles |
Travel, Accommodations, Expenses - MSD |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pierre Fabre |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; MSD |
Consulting or Advisory Role - Bristol-Myers Squibb; MSD |
Speakers' Bureau - Bristol-Myers Squibb; MSD |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche/Genentech; Sanofi |
Research Funding - Pierre Fabre |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; pierre fabre; Roche |
|
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Pierre Fabre |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pierre Fabre |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis |
Travel, Accommodations, Expenses - Novartis; Pierre Fabre |
|
|
Consulting or Advisory Role - BMS; MSD Oncology; Pierre Fabre |
Research Funding - BMS (Inst); LEO Pharma (Inst) |
Travel, Accommodations, Expenses - BMS; MSD Oncology; MSD Oncology; Pierre Fabre |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sun Pharma |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Novartis |
|
|
No Relationships to Disclose |